Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Evolent Health Q3 2026 10-Q: 113M Shares Outstanding

Evolent Health, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Shwetambri Chauhan | 05 November 2026

Shutterstock Names Scott Grossman Interim CFO

Shutterstock, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing the appointment of Scott Grossman as Interim Chief Financial Officer effective November 2, 2026, alongside the departure of outgoing CFO Rik Powell, and announcing third-quarter 2026 financial results.

Aakashdeep | 05 November 2026

Shutterstock Q3 2026: Cash Falls to $110.5M, Shares at 37M

Shutterstock, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, disclosing balance sheet data including cash, receivables, and share count.

Nitish Kishor | 05 November 2026

Shake Shack Q3 2026: Total Assets Rise to $1.99 Billion

Shake Shack Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the thirteen and thirty-nine weeks ended September 30, 2026, and reporting total assets of $1,985,295 thousand as of that date.

Shwetambri Chauhan | 05 November 2026

Korro Bio Files Q3 2026 Report, 13.7M Shares Outstanding

Korro Bio, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 5, 2026, disclosing operational updates including its ongoing ANCHOR clinical trial and the pending termination of its Novo Nordisk collaboration.

Aditi Sarkar | 05 November 2026

Fate Therapeutics Q3 2026 10-Q: 121.6M Shares Outstanding

Fate Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three and nine months ended September 30, 2026, disclosing operational and financial information for its iPSC-derived cell therapy pipeline.

Aditi Sarkar | 05 November 2026

Commerce.com Q3 2026: Net Loss of $3.2M, Nine-Month Profit of $1.6M

Commerce.com, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting a net loss of $3.214 million for the third quarter while posting net income of $1.617 million for …

Nitish Kishor | 05 November 2026

Entrada Therapeutics Files Q3 2026 Form 10-Q

Entrada Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Shwetambri Chauhan | 05 November 2026

TIC Solutions Q3 2026: Revenue Rises to $639.6M

TIC Solutions, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter revenue of $639.6 million and a net loss of $11.1 million.

Aakashdeep | 05 November 2026

Centrus Energy Files Q3 2026 Report With 19.9M Shares Outstanding

Centrus Energy Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing share counts, segment details, and key contract activity.

Shwetambri Chauhan | 05 November 2026
Support

Hi! How can we help you today?

Loading…